Infectious Disease Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: IB526CE82977EN
Market Monitor Global

Abstracts

Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission.

This report contains market size and forecasts of Infectious Disease Drugs in Global, including the following market information:

Global Infectious Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Infectious Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibacterials Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Infectious Disease Drugs include GlaxoSmithKline, Gilead Sciences, Merck & Co., Pfizer, Sanofi, AbbVie, Shire, Grifols and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Infectious Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Infectious Disease Drugs Market Segment Percentages, by Type, 2021 (%)

• Antibacterials
• Antiviral drugs
• Antiparasitic drugs
• Antifungal
• Others

Global Infectious Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Infectious Disease Drugs Market Segment Percentages, by Application, 2021 (%)

• HIV
• Malaria
• Hepatitis
• Influenza
• HPV
• Tuberculosis
• Others

Global Infectious Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Infectious Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Infectious Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Infectious Disease Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Gilead Sciences
• Merck & Co.
• Pfizer
• Sanofi
• AbbVie
• Shire
• Grifols
• Johnson & Johnson
• Protein Sciences
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Infectious Disease Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Infectious Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INFECTIOUS DISEASE DRUGS OVERALL MARKET SIZE

2.1 Global Infectious Disease Drugs Market Size: 2021 VS 2028
2.2 Global Infectious Disease Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Infectious Disease Drugs Players in Global Market
3.2 Top Global Infectious Disease Drugs Companies Ranked by Revenue
3.3 Global Infectious Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Infectious Disease Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Infectious Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Disease Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Infectious Disease Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Infectious Disease Drugs Market Size Markets, 2021 & 2028
  4.1.2 Antibacterials
  4.1.3 Antiviral drugs
  4.1.4 Antiparasitic drugs
  4.1.5 Antifungal
  4.1.6 Others
4.2 By Type - Global Infectious Disease Drugs Revenue & Forecasts
  4.2.1 By Type - Global Infectious Disease Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Infectious Disease Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Infectious Disease Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Infectious Disease Drugs Market Size, 2021 & 2028
  5.1.2 HIV
  5.1.3 Malaria
  5.1.4 Hepatitis
  5.1.5 Influenza
  5.1.6 HPV
  5.1.7 Tuberculosis
  5.1.8 Others
5.2 By Application - Global Infectious Disease Drugs Revenue & Forecasts
  5.2.1 By Application - Global Infectious Disease Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Infectious Disease Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Infectious Disease Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Infectious Disease Drugs Market Size, 2021 & 2028
6.2 By Region - Global Infectious Disease Drugs Revenue & Forecasts
  6.2.1 By Region - Global Infectious Disease Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Infectious Disease Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Infectious Disease Drugs Revenue, 2017-2028
  6.3.2 US Infectious Disease Drugs Market Size, 2017-2028
  6.3.3 Canada Infectious Disease Drugs Market Size, 2017-2028
  6.3.4 Mexico Infectious Disease Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Infectious Disease Drugs Revenue, 2017-2028
  6.4.2 Germany Infectious Disease Drugs Market Size, 2017-2028
  6.4.3 France Infectious Disease Drugs Market Size, 2017-2028
  6.4.4 U.K. Infectious Disease Drugs Market Size, 2017-2028
  6.4.5 Italy Infectious Disease Drugs Market Size, 2017-2028
  6.4.6 Russia Infectious Disease Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Infectious Disease Drugs Market Size, 2017-2028
  6.4.8 Benelux Infectious Disease Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Infectious Disease Drugs Revenue, 2017-2028
  6.5.2 China Infectious Disease Drugs Market Size, 2017-2028
  6.5.3 Japan Infectious Disease Drugs Market Size, 2017-2028
  6.5.4 South Korea Infectious Disease Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Infectious Disease Drugs Market Size, 2017-2028
  6.5.6 India Infectious Disease Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Infectious Disease Drugs Revenue, 2017-2028
  6.6.2 Brazil Infectious Disease Drugs Market Size, 2017-2028
  6.6.3 Argentina Infectious Disease Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Infectious Disease Drugs Revenue, 2017-2028
  6.7.2 Turkey Infectious Disease Drugs Market Size, 2017-2028
  6.7.3 Israel Infectious Disease Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Infectious Disease Drugs Market Size, 2017-2028
  6.7.5 UAE Infectious Disease Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Infectious Disease Drugs Major Product Offerings
  7.1.4 GlaxoSmithKline Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Gilead Sciences
  7.2.1 Gilead Sciences Corporate Summary
  7.2.2 Gilead Sciences Business Overview
  7.2.3 Gilead Sciences Infectious Disease Drugs Major Product Offerings
  7.2.4 Gilead Sciences Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.2.5 Gilead Sciences Key News
7.3 Merck & Co.
  7.3.1 Merck & Co. Corporate Summary
  7.3.2 Merck & Co. Business Overview
  7.3.3 Merck & Co. Infectious Disease Drugs Major Product Offerings
  7.3.4 Merck & Co. Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.3.5 Merck & Co. Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Infectious Disease Drugs Major Product Offerings
  7.4.4 Pfizer Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Infectious Disease Drugs Major Product Offerings
  7.5.4 Sanofi Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 AbbVie
  7.6.1 AbbVie Corporate Summary
  7.6.2 AbbVie Business Overview
  7.6.3 AbbVie Infectious Disease Drugs Major Product Offerings
  7.6.4 AbbVie Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.6.5 AbbVie Key News
7.7 Shire
  7.7.1 Shire Corporate Summary
  7.7.2 Shire Business Overview
  7.7.3 Shire Infectious Disease Drugs Major Product Offerings
  7.7.4 Shire Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.7.5 Shire Key News
7.8 Grifols
  7.8.1 Grifols Corporate Summary
  7.8.2 Grifols Business Overview
  7.8.3 Grifols Infectious Disease Drugs Major Product Offerings
  7.8.4 Grifols Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.8.5 Grifols Key News
7.9 Johnson & Johnson
  7.9.1 Johnson & Johnson Corporate Summary
  7.9.2 Johnson & Johnson Business Overview
  7.9.3 Johnson & Johnson Infectious Disease Drugs Major Product Offerings
  7.9.4 Johnson & Johnson Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.9.5 Johnson & Johnson Key News
7.10 Protein Sciences
  7.10.1 Protein Sciences Corporate Summary
  7.10.2 Protein Sciences Business Overview
  7.10.3 Protein Sciences Infectious Disease Drugs Major Product Offerings
  7.10.4 Protein Sciences Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.10.5 Protein Sciences Key News
7.11 AstraZeneca
  7.11.1 AstraZeneca Corporate Summary
  7.11.2 AstraZeneca Business Overview
  7.11.3 AstraZeneca Infectious Disease Drugs Major Product Offerings
  7.11.4 AstraZeneca Infectious Disease Drugs Revenue in Global Market (2017-2022)
  7.11.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Infectious Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Infectious Disease Drugs Market Drivers in Global Market
Table 3. Infectious Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Infectious Disease Drugs in Global Market
Table 5. Top Infectious Disease Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Infectious Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Infectious Disease Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Infectious Disease Drugs Product Type
Table 9. List of Global Tier 1 Infectious Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Infectious Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Infectious Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Infectious Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Infectious Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Infectious Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Infectious Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Infectious Disease Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Infectious Disease Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Infectious Disease Drugs Product Offerings
Table 32. GlaxoSmithKline Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Sciences Corporate Summary
Table 34. Gilead Sciences Infectious Disease Drugs Product Offerings
Table 35. Gilead Sciences Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Merck & Co. Corporate Summary
Table 37. Merck & Co. Infectious Disease Drugs Product Offerings
Table 38. Merck & Co. Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Infectious Disease Drugs Product Offerings
Table 41. Pfizer Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Infectious Disease Drugs Product Offerings
Table 44. Sanofi Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 45. AbbVie Corporate Summary
Table 46. AbbVie Infectious Disease Drugs Product Offerings
Table 47. AbbVie Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Shire Corporate Summary
Table 49. Shire Infectious Disease Drugs Product Offerings
Table 50. Shire Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Grifols Corporate Summary
Table 52. Grifols Infectious Disease Drugs Product Offerings
Table 53. Grifols Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Johnson & Johnson Corporate Summary
Table 55. Johnson & Johnson Infectious Disease Drugs Product Offerings
Table 56. Johnson & Johnson Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Protein Sciences Corporate Summary
Table 58. Protein Sciences Infectious Disease Drugs Product Offerings
Table 59. Protein Sciences Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 60. AstraZeneca Corporate Summary
Table 61. AstraZeneca Infectious Disease Drugs Product Offerings
Table 62. AstraZeneca Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Infectious Disease Drugs Segment by Type in 2021
Figure 2. Infectious Disease Drugs Segment by Application in 2021
Figure 3. Global Infectious Disease Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Disease Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2021
Figure 8. By Type - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 12. US Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 24. China Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Infectious Disease Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Sciences Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck & Co. Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AbbVie Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Shire Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Grifols Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson & Johnson Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Protein Sciences Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AstraZeneca Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)